Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anjali A. Joglekar"'
Autor:
James Hakim, Matthew J. Mimiaga, Katie B. Biello, Thomas B. Campbell, Anjali A. Joglekar, Steven A. Safren, Ann Walawander, Jocelyn E. Remmert, Laura M. Smeaton, Wadzanai Samaneka, David D. Celentano, Umesh G. Lalloo, Nagalingeswaran Kumarasamy, Mulinda Nyirenda, Javier R. Lama, Aspara Nair, Aadia Rana, Ana Martinez, Virginia Kayoyo
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e104178 (2014)
PLoS ONE
PLoS ONE
Background PEARLS, a large scale trial of antiretroviral therapy (ART) for HIV (n = 1,571, 9 countries, 4 continents), found that a once-daily protease inhibitor (PI) based regimen (ATV+DDI+FTC), but not a once-daily non-nucleoside reverse transcript
Autor:
David Chilongozi, Sharla Faesen, Breno Santos, Mamta K. Jain, Pablo Tebas, Apsara Nair, Cynthia Riviere, Beatriz Grinsztejn, Sima Berendes, Steve Tabet, Joan Gormley, M. Graham Ray, Johnstone Kumwenda, Judith Feinberg, Todd Stroberg, Kenneth H. Mayer, Nikki Gettinger, Vicki L. Bailey, James Hakim, Selvamuthu Poongulali, Sandra W. Cardoso, Marineide Gonçalves de Melo, Karin L. Klingman, Rosie Mngqibisa, Thomas B. Campbell, Amneris E. Luque, Beverly Putnam, Thira Sirisanthana, Janice M. Fritsche, Ann Walawander, Ge Youl Kim, Roberto Corales, Richard B. Pollard, Ronald T. Mitsuyasu, Martha Silberman, Rita Alves Lira, Janet Forcht, Norbert Bischofberger, Ana Martinez, Barbara Brizz, Laura M. Smeaton, Asmita Gaikwad, Farida Amod, Srikanth Tripathy, Babafemi Taiwo, Anthony Chisada, Chiedza Maponga, Charles van der Horst, Michael Wulfsohn, Javier R. Lama, Taha E. Taha, Manuel Revuelta, Christine Hurley, David Currin, Wendy Snowden, Keith A. Pappa, Rosa Infante, T. Petersen, Donna V. McGregor, Susan Cu-Uvin, Susan A. Fiscus, Eric S. Daar, Jody Lawrence, P. Jan Geiseler, Irving F. Hoffman, Luis Lopez-Detres, Karen T. Tashima, Larisa Zifchak, Victor De Gruttola, Timothy P. Flanigan, Laura Moran, Farideh Said, Alberto La Rosa, Raman R. Gangakhedkar, Maria Palmer, Michael F. Para, Joel E. Gallant, Nancy Webb, Cecilia Kanyama, Wadzanai Samaneka, Jabin Sharma, Yvonne J. Bryson, Mark A. Winters, Ian Sanne, David Shugarts, Yun Chen, Sampada Dhayarkar, Peter N. Kazembe, Scott M. Hammer, Adriana Andrade, Robert T. Schooley, Beth D. Mullan, Henry H. Balfour, Patrice Severe, Beverly E. Sha, Madeline Torres, Cathi Basler, Andrew K. Cheng, Jolene Noel-Connor, Vladimir Berthaud, Jonathan Uy, Michael K. Klebert, Virginia Kayoyo, Donna Mildvan, David W. Haas, Joseph J. Eron, Cheryl Mogridge, David D. Celentano, Ruben Lopez, Ronald L. Barnett, Karin Nielsen, Helen Patterson, Renard S. Descallar, Jenifer Baer, Deise Lucia Faria, Cheryl Marcus, Khuanchai Supparatpinyo, Mina C. Hosseinipour, Newton Kumwenda, Yvette Delph, Smanga Ntshele, Edith Swann, Steven A. Safren, David M. Asmuth, Kelly Burke, Laurie Frarey, Joseph Steele, Gary M. Cox, Umesh G. Lalloo, Richard B. Pendame, Mary Adams, Bharat Ramratnam, Christine Wanke, James F. Rooney, Francis Martinson, Edde Loeliger, Anjali A. Joglekar, John Martin, Myron S. Cohen, Sheela Godbole, Robert C. Bollinger, Roy M. Gulick, Cynthia Firnhaber, Charles Flexner, William A. O'Brien, Suniti Solomon, Jorge Sanchez, Yue Chen, Susan H. Eshleman, Kathy J. Watson, N. Kumarasamy, David H. Haas, Ann C. Collier, Bartolo Santos, Suwat Chariyalertsak, Michelle S. Cespedes, Howard Jaffe, Judith S. Currier
Publikováno v:
PLoS medicine, vol 9, iss 8
PLoS Medicine, Vol 9, Iss 8, p e1001290 (2012)
PLoS Medicine, Vol 9, Iss 8, p e1001290 (2012)
BackgroundAntiretroviral regimens with simplified dosing and better safety are needed to maximize the efficiency of antiretroviral delivery in resource-limited settings. We investigated the efficacy and safety of antiretroviral regimens with once-dai
Autor:
Safren SA; Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America; The Fenway Institute, Fenway Health, Boston, MA, United States of America., Biello KB; The Fenway Institute, Fenway Health, Boston, MA, United States of America; Harvard School of Public Health, Boston, MA, United States of America., Smeaton L; Harvard School of Public Health, Boston, MA, United States of America., Mimiaga MJ; Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America; The Fenway Institute, Fenway Health, Boston, MA, United States of America; Harvard School of Public Health, Boston, MA, United States of America., Walawander A; Frontier Science and Technology Research Foundation, Amherst, NY, United States of America., Lama JR; Asociacion Civil Impacta Salud y Educacion, Lima, Peru., Rana A; Alpert Medical School/The Miriam Hospital, Providence, RI, United States of America., Nyirenda M; College of Medicine - Johns Hopkins Research Project, Blantyre, Malawi., Kayoyo VM; University of North Carolina Project, Lilongwe, Malawi., Samaneka W; University of Zimbabwe-University of California San Francisco Collaborative Research Program, Harare, Zimbabwe., Joglekar A; National AIDS Research Institute, Pune, India., Celentano D; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America., Martinez A; NIH/NIAD/DAIDS Pharmaceutical Affairs, Bethesda, MD, United States of America., Remmert JE; Massachusetts General Hospital, Boston, MA, United States of America., Nair A; Frontier Science and Technology Research Foundation, Amherst, NY, United States of America., Lalloo UG; Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, S. Africa., Kumarasamy N; YRGCARE Medical Centre, Chennai, India., Hakim J; University of Zimbabwe, Harare, Zimbabwe, Africa., Campbell TB; University of Colorado Denver, Aurora, CO, United States of America.
Publikováno v:
PloS one [PLoS One] 2014 Aug 25; Vol. 9 (8), pp. e104178. Date of Electronic Publication: 2014 Aug 25 (Print Publication: 2014).